Derek Meisner
2022 - Acumen Pharmaceuticals
In 2022, Derek Meisner earned a total compensation of $1.3M as Chief Legal Officer at Acumen Pharmaceuticals.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Non-Equity Incentive Plan | $52,925 |
| Option Awards | $1,039,500 |
| Salary | $141,705 |
| Other | $538 |
| Total | $1,279,668 |
Meisner received $1M in option awards, accounting for 81% of the total pay in 2022.
Meisner also received $45K in bonus, $52.9K in non-equity incentive plan, $141.7K in salary and $538 in other compensation.
Rankings
In 2022, Derek Meisner's compensation ranked 2,559th out of 5,760 executives tracked by ExecPay. In other words, Meisner earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,559 out of 5,760 | 56th |
Division Manufacturing | 1,413 out of 3,136 | 55th |
Major group Chemicals And Allied Products | 642 out of 1,422 | 55th |
Industry group Drugs | 596 out of 1,323 | 55th |
Industry Biological Products, Except Diagnostic Substances | 149 out of 291 | 49th |
Source: SEC filing on April 27, 2023.
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at Acumen Pharmaceuticals in 2022.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021